Is ELDN or ENLV more undervalued in 2026?

CirclFi compares Eledon Pharmaceuticals, Inc. (ELDN) and Enlivex Ltd. (ENLV) using 13 institutional-grade valuation models. ELDN has a Quality of Company score of 3.9/10 while ENLV scores 1.6/10.

Which is a better buy — ELDN or ENLV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ELDN and ENLV valuations compare?

ELDN at $3.87 and ENLV at $0.76 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ELDN vs ENLV Valuation Comparison 2026 — Intrinsic Value Analysis

ELDN

Biotechnology

Eledon Pharmaceuticals, Inc.

Quality

3.9

out of 10

Value Trap

SAFE

Price

$3.87

Last close

Models

7/13

Active

ENLV

Biotechnology

Enlivex Ltd.

Quality

1.6

out of 10

Value Trap

SAFE

Price

$0.76

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ELDN Fair Value	ELDN Upside	ENLV Fair Value	ENLV Upside
Bayesian DCF	Intrinsic	$1.08	-72.1%	$0.20	-73.5%
EROIC Spread	Intrinsic	—	—	$0.39	-51.7%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.11	-97.0%	$1.39	+81.7%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ELDN vs ENLV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ELDN vs ENLV — Which Stock Is More Undervalued?

ELDN scores higher with a 3.9/10 quality rating vs ENLV's 1.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Eledon Pharmaceuticals, Inc. (ELDN) and Enlivex Ltd. (ENLV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ELDN currently trades at $3.87 with a QOC of 3.9/10, while ENLV trades at $0.76 with a QOC of 1.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).